These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5609888)

  • 1. [5-hydroxyindoleacetic acid elimination during acute coronary insufficiency, with or without myocardial necrosis].
    Navarret EE; Sánchez B; Alperovich M; Resio J; López Martín A; Giardini JA
    Prensa Med Argent; 1967 May; 54(12):551-5. PubMed ID: 5609888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lowering of 5-hydroxyindoleacetic acid excretion through nitroglycerin].
    Reinhold D; Plötner G
    Z Gesamte Inn Med; 1967 May; 22(10):302-6. PubMed ID: 4967544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin metabolism in acute coronary insufficiency].
    Semenovich NI; Chupeeva NG
    Ter Arkh; 1971 Feb; 43(2):34-8. PubMed ID: 5117905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Excretion of vanilmandelic and 5-hydroxyindoleacetic acids in acute myocardial infarct].
    Detsik IuI; Klitina SE; Fesenko IT
    Vrach Delo; 1978 Oct; (10):16-20. PubMed ID: 716351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levels of serotonin in the blood and 5-hydroxyindoleacetic acid in the urine of patients with ischemic heart disease].
    Buslenko NS; Kuznetsova BA
    Kardiologiia; 1972 Sep; 12(9):39-43. PubMed ID: 4644951
    [No Abstract]   [Full Text] [Related]  

  • 6. The urinary elimination of vanillyl mandelic acid and 5-hydroxyindoleacetic acid in healthy Puerto Ricans.
    Suárez RM; Alvarado F; Suárez RM; Olavarrieta S
    Bol Asoc Med P R; 1967 May; 59(5):216-21. PubMed ID: 5232816
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diurnal urinary excretion of serotonin and 5-hydroxyindoleacetic acid in chronic liver diseases].
    Szpakowicz T
    Pol Tyg Lek; 1980 Jan; 35(3):77-9. PubMed ID: 6154291
    [No Abstract]   [Full Text] [Related]  

  • 8. [5-hydroxyindoleacetic acid excretion in dumping syndrome].
    Teichmann W; Reding R; Knapp A
    Zentralbl Chir; 1969 Jul; 94(27):906-8. PubMed ID: 5368171
    [No Abstract]   [Full Text] [Related]  

  • 9. [The age dependence of 5-hydroxyindoleacetic acid excretion in the urine].
    Emmrich R; Schaaf J
    Z Gesamte Inn Med; 1968 Sep; 23(18):551-3. PubMed ID: 5706732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of 3-methoxy-4-hydroxy-amygdalic acid and 5-hydroxyindoleacetic acid in the urine of patients with depressive states].
    Slowik S
    Przegl Lek; 1968; 24(3):367-70. PubMed ID: 5676274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the use of sodium hydroxybutyrate in patients with acute coronary insufficiency and cardiac rhythm disorders].
    Popov VG; Kharkevich DA; Syrkin AL; Basistov AF; Lazebnik LB; Lazutin VK
    Ter Arkh; 1968 Dec; 40(12):44-7. PubMed ID: 5746542
    [No Abstract]   [Full Text] [Related]  

  • 12. [The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine].
    Simon J; Láhn V; Opatrný K; Sova J; Sídlová A; Cerhová M; Hůla J; Virt S
    Cas Lek Cesk; 1968 Mar; 107(13):394-8. PubMed ID: 5664817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Excretion of 5-hydroxyindoleacetic acid and subjective symptoms in human gastric and duodenal ulcers].
    Pokora J; Czarnecki J; Matuszewski M
    Pol Tyg Lek; 1969 May; 24(21):794-7. PubMed ID: 5804330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary elimination of 5-hydroxyindolacetic acid (5HIAA) and 3-methoxy-4-hydroxy-mandelic acid (VMA) and test of serotonin conversion in the course of natural and surgical menopause].
    Gasparri F; Periti P; Battaglia GB
    Boll Soc Ital Biol Sper; 1966 Jul; 42(13):851-4. PubMed ID: 5967362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 16. The way of excretion of 5-hydroxyindole acetic acid.
    Rysánek K; Spánková H; Mlejnková M
    Act Nerv Super (Praha); 1970 Jan; 12(1):75-7. PubMed ID: 5418668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thromboelastographic control of blood coagulability during anticoagulant therapy of patients with coronary insufficiency under ambulatory conditions].
    Demin AA; Romashchov VP
    Klin Med (Mosk); 1966 Jan; 44(1):51-4. PubMed ID: 5984426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increase of 5-hydroxyindolylacetic acid excretion in early and late stages of myocardial infarct. 1. Methodical and clinical studies].
    Reinhold D; Plötner G; Jordan J
    Z Gesamte Inn Med; 1966 Mar; 21(5):151-6. PubMed ID: 5988469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of urinary concentrations of the metabolites of various neurohormones in cases of acute poisoning with hypnotic and psychotropic drugs and carbon monoxide].
    Marczyk-Baryła I
    Wiad Lek; 1980 May; 33(9):695-9. PubMed ID: 6157255
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism of serotonin. XI. Further research on the elimination of 5-hydroxy-indoleacetic acid in chronic bronchitis].
    Pipitone V; Carrozzo M; Numo R
    Boll Soc Ital Biol Sper; 1964 Nov; 40(21):1351-3. PubMed ID: 5877075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.